methysergide has been researched along with Peritoneal Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| BARTHOLOMEW, LG; ROOKE, ED; SPITTELL, JA; UTZ, DC | 1 |
| Langer, JC; Liebman, SM; Monk, PK; Pelletier, GJ | 1 |
2 other study(ies) available for methysergide and Peritoneal Diseases
| Article | Year |
|---|---|
RETROPERITONEAL FIBROSIS IN PATIENTS TAKING METHYSERGIDE.
Topics: Drug Therapy; Duodenal Ulcer; Humans; Hydronephrosis; Methysergide; Migraine Disorders; Peritoneal Diseases; Prednisone; Retroperitoneal Fibrosis; Toxicology; Ureteral Obstruction; Urography | 1965 |
Mast cell mediators and peritoneal adhesion formation in the rat.
Topics: Animals; Azepines; Disease Models, Animal; Histamine Antagonists; Leukotriene D4; Male; Mast Cells; Methysergide; Ondansetron; Peritoneal Diseases; Platelet Activating Factor; Propionates; Pyrilamine; Quinolines; Ranitidine; Rats; Rats, Sprague-Dawley; Serotonin Antagonists; Tissue Adhesions; Triazoles | 1995 |